Top Markets
Coin of the day
Algorae Pharmaceuticals Limited Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limited

1AI
Classement en actions #30360
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Prix de l'action
$0.00846342
Capitalisation boursière
$17.16M
Changement (1 jour)
9.09%
Changement (1 an)
87.30%
Pays
AU
Échange Algorae Pharmaceuticals Limited (1AI)

Catégorie

Historique du prix de l'action pour Algorae Pharmaceuticals Limited (1AI)
Prix de clôture le plus élevé : $0.01 le 2026-08-01

Prix de clôture le plus bas : $0.01 le 2023-08-01
Historique du prix de l'action de Algorae Pharmaceuticals Limited de 2023 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -10.71%
2025 104.60%
2024 -39.97%
2023 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$527.89 35.09%
US
$996.61 51.72%
NL
$115.74 -20.49%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE